Aclarion, Inc. (ACON) stock
ACONNasdaqServices-Medical LaboratoriesFiscal year ends December 31Also trades as ACONW
$1.56−0.03 (-1.89%)
Close on Nov 13, 2026Market cap $4.50MP/E –Yield –
Aclarion price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Aclarion's price to sales ratio was 47.9× on Nov 11, 2026, against 54.0× a year earlier. Over the last 5 years it ranged from 0.2× to 143.6×, with a median of 39.7×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 47.9× | +8.2 |
| 2025 | Dec 31, 2025 | 39.7× | +10.4 |
| 2024 | Dec 31, 2024 | 29.3× | +9.7 |
| 2023 | Dec 29, 2023 | 19.6× | −55.5 |
| 2022 | Dec 30, 2022 | 75.0× | – |
See a number that looks wrong?